Addiction among the middle class
Review by Josh Eisen / June 27, 2017 / 4 min read
In recent years, my newsfeed has played host to a steady trickle of articles documenting the alarming rise of opioid addiction rates in North America. Described by political pundits as a “quiet epidemic,” the explosion in the use and abuse of pharmaceutical opioids — substances with clinical names like oxycodone, fentanyl, hydromorphone — has gone largely unnoticed, media coverage often limited to celebrity overdoses and litanies of dreary statistics.